Mechanism research on network pharmacology of Achyranthis bidentatae radix intreating knee osteoarthritis
10.3760/cma.j.cn115398-20190823-00163
- VernacularTitle:牛膝治疗膝骨关节炎的网络药理学机制研究
- Author:
Ran LYU
1
;
Neng CHEN
;
Xiaojun JIA
;
Huashan QUAN
;
Minlong LI
;
Fang TAN
Author Information
1. 广州中医药大学第二附属医院，广东省中医院珠海医院骨一科，珠海 519000
- From:
International Journal of Traditional Chinese Medicine
2020;42(6):567-572
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the active ingredients and mechanisms of Achyranthis bidentatae radix in treating knee osteoarthritis (KOA) .Methods:To detect theingredients in Achyranthis bidentatae radix from TCMSP and screen its active components so as to abtain the potential targets of those active components. By searching from the TCMSP, to explore the targets of KOA. Then, by integrating the chemical compound and disease targets to construct its network and to analize the gene ontology (GO) enrichment and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment. Result:There are 23 active compounds in Achyranthis Bidentatae radix, corresponding to 136 targets of KOA. By GO enrichment analysis, there are 1 592 GO terms related to biological process. By KEGG pathway enrichment analysis, there are 19 KEGG pathways, including IL-17 signaling pathway, TNF signaling pathway, Apoptosis, and PI3K/AKT signaling pathway. Conclusions:The Achyranthis bidentatae radix could treat KOA by reducing inflammatory damage by regulating immune inflammatory response in the knee joint, and inhibiting chondrocyte apoptosis to protect cartilage.
